RECURRENT GLIOBLASTOMA, IDH-WILDTYPE
Clinical trials for RECURRENT GLIOBLASTOMA, IDH-WILDTYPE explained in plain language.
Never miss a new study
Get alerted when new RECURRENT GLIOBLASTOMA, IDH-WILDTYPE trials appear
Sign up with your email to follow new studies for RECURRENT GLIOBLASTOMA, IDH-WILDTYPE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New brain implant shows promise against deadly recurrent cancer
Disease control Not yet recruitingThis study is testing whether adding a new implant called Cerebraca Wafer to standard chemotherapy helps people with recurrent glioblastoma, a serious brain cancer, live longer. The trial will compare two groups: one receiving the wafer implant plus chemotherapy after surgery, an…
Matched conditions: RECURRENT GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE2, PHASE3 • Sponsor: Everfront Biotech Co., Ltd. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Scientists test 'Tiny Warhead' therapy to target deadly recurrent brain tumors
Disease control Not yet recruitingThis early-stage study is testing a new two-drug combination for glioblastoma, an aggressive brain cancer that has returned after initial treatment. The first drug is a radioactive antibody designed to find and deliver radiation directly to cancer cells. The second drug is an imm…
Matched conditions: RECURRENT GLIOBLASTOMA, IDH-WILDTYPE
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC